Skip to content
DrSoniaFamily Medicine Canada
← Back to Prescribing

Prescribing

SABA reliever dosing

Short-acting beta-agonist use for quick symptom relief in asthma.

Last reviewed 2026-01-05|respiratory | asthma | medication

Jump to

Dosing tableContraindicationsRenal and hepatic considerationsPregnancy and lactation cautionsMonitoring checkpointsStop or escalate criteria

Dosing quick reference

Medication (generic)

Salbutamol MDI (100 mcg/puff)

Starting dose

1-2 puffs every 4-6 hours as needed

Typical titration / target

Use spacer when possible; reassess if frequent use

Monitoring / notes

Frequent use (>2 days/week) suggests inadequate control.

Contraindications

  • Avoid in known salbutamol hypersensitivity.
  • Do not rely on frequent reliever-only use as a substitute for controller optimization.
  • Reassess risk in patients with severe tachyarrhythmia or medication-triggered adverse effects.

Renal and hepatic considerations

  • Routine inhaled reliever dosing usually does not require renal or hepatic adjustment.
  • In severe comorbidity, monitor for systemic beta-agonist adverse effects when use becomes frequent.
  • Review interacting medications that may increase tachycardia or electrolyte risk.

Pregnancy and lactation cautions

  • Maintain maternal respiratory stability with individualized treatment planning in pregnancy.
  • Use the minimum effective reliever exposure while optimizing controller strategy.
  • During lactation, confirm current compatibility guidance and monitor if frequent dosing is needed.

Monitoring checkpoints

  • Teach spacer technique and inhaler priming.
  • Track reliever frequency; use above 2 days/week signals inadequate control.
  • Review action plan and when to seek urgent care.

Stop or escalate criteria

  • Escalate urgently for worsening breathlessness, poor response to reliever, or hypoxia signs.
  • Escalate controller therapy if reliever use increases.
  • Stop routine self-escalation and reassess promptly if palpitations, tremor, or chest discomfort become significant.

References